People with lung cancer are more likely to have microplastics in their lungs and to have larger quantities of microplastics in their lungs, according to research that will be presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain [1]. Researchers say their study adds to evidence that microplastics are entering our bodies via […]
Category: Cancer
Thymus radiation is linked to worse outcomes in patients with non-small cell lung cancer
Until recently, the thymus was thought to be of little use beyond puberty, but new research has shown that radiation to the organ is associated with worse outcomes in patients being treated for non-small cell lung cancer (NSCLC). In a study published in the leading cancer journal Annals of Oncology [1], researchers analysed 1,107 patients […]
Large-scale European study shows that prevention in patients with inherited cancer risks produces substantial cost benefits
Gothenburg, Sweden: Screening people with the rare, inherited cancer-causing condition Li-Fraumeni syndrome (LFS) brings both medical and economic benefits to patients and healthcare systems, according to research presented to the annual conference of the European Society of Human Genetics. The study, the first of its kind to look at these benefits Europe-wide, makes a convincing […]
Integrating genetic origin data with tumour analyses enables better prediction of survival
Gothenburg, Sweden: New research to be presented at the annual conference of the European Society of Human Genetics shows that a cancer patient’s genetic ancestry can have a significant effect both on how their disease progresses and their survival. In the largest study of its kind, researchers examined nearly 1,900 specific genetic changes in tumours […]
Weight loss treatments linked to lower risk of obesity-related cancers in people without diabetes
A study of more than 229,000 obese adults without diabetes in the United States has shown that weight loss drugs are associated with a decreased risk of obesity-related cancers. The research found that GLP-1 receptor agonists (GLP-1 RAs), such as semaglutide (brand names: Ozempic, Wegovy) and tirzepatide (brand names: Mounjaro and Zepbound), were associated with […]
Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side effects
Stockholm, Sweden: Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of radiotherapy, according to results presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026). Experts say the research brings us one step closer to safe and effective radiotherapy in […]
Breast cancer that has begun to spread could be controlled for longer with targeted radiotherapy
Stockholm, Sweden: Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer without their cancer getting worse, according to the results of a small randomised controlled trial presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026) [1]. Once cancer has […]
Meeting an AI doctor before a real-life consultation improves cancer patients’ understanding and reduces stress
Stockholm, Sweden: Cancer patients who interact with an artificial intelligence (AI) avatar doctor before they meet their real-life consultant feel more knowledgeable and less stressed, according to research presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026) [1]. The study was presented by Dr Adam Raben, Chair of Radiation Oncology […]
Blood test that detects tumour DNA could help guide treatment when cancer has spread
Stockholm, Sweden: A blood test that detects tumour DNA circulating in the bloodstream may help select the most effective treatment options for cancer patients whose tumours have started to spread, according to one of the largest randomised controlled trials of its kind presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026) [1]. […]
Share proton therapy across national borders and plan five new centres in Romania, Greece, Italy, Northern Ireland and Poland to maximise access for patients in Europe
— Researchers working to make proton beam therapy safe and effective for pregnant cancer patients — Stockholm, Sweden: Existing proton therapy centres mean that 59% of cancer patients across Europe currently have reasonable access to this specialist radiotherapy, according to research that will be presented the Congress of the European Society for Radiotherapy and Oncology […]